FOR IMMEDIATE RELEASE 10 September 2024
ENQUEST PLC ("EnQuest" or "the Company")
TRANSACTIONS IN OWN SHARES
EnQuest PLC (the "Company") announces that, on 9 September 2024, it purchased the following number of its ordinary shares of 5 pence each (the "Ordinary Shares") through Merrill Lynch International ("Merrill Lynch"). Such purchase was effected pursuant to the instructions issued by the Company in accordance with the share repurchase arrangements entered into with Merrill Lynch, as announced on 29 April 2024.
Aggregated information of Ordinary Shares purchased on 9 September 2024 according to each trading venue:
| Venue | Weighted average price paid per share (GBp) | Aggregate number of shares purchased | Lowest price paid per share (GBp) | Highest price paid per share (GBp) |
| London Stock Exchange | 11.58 | 472,100 | 11.56 | 11.80 |
| Chi-X | 11.62 | 3,666 | 11.56 | 11.66 |
| BATS | - | - | - | - |
| Turquoise | - | - | - | - |
| Total (all venues) | 11.58 | 475,766 | 11.56 | 11.80 |
Since 29 April 2024, the Company has purchased 29,422,026 Ordinary Shares at a cost (including dealing and associated costs) of £4,041,234.06. Of those shares, 25,000,000 Ordinary Shares have been retained in Treasury and will be issued in due course to the Company's Employee Benefit Trust and 4,422,026 Ordinary Shares have been purchased for cancellation.
Following the cancellation of the purchased shares, there will be 1,911,502,313 Ordinary Shares in issue and 25,000,000 Shares in Treasury. The total voting rights in the Company will accordingly be 1,886,502,313. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.
A full breakdown of the individual trades made by Merrill Lynch on behalf of the Company as part of the share repurchase programme is attached to this document.
Attachment: http://www.rns-pdf.londonstockexchange.com/rns/5027D_1-2024-9-9.pdf
LEI: 2138008LJU6WFQWOXJ73
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
Enquiries:
EnQuest plc +44 (0)20 7925 4900
Kate Christ, Company Secretary
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
